Evonik Venture Capital is the corporate venture arm of Evonik Industries AG, a global specialty chemicals company.
Evonik Venture Capital generates strategic value and growth opportunities through investing and partnering with innovative start-up companies. With a fund size of EUR 400 million, Evonik Venture Capital has made more than 55 investments since 2012, both direct and fund investments. The investment scope ranges from early-stage to growth-stage with an investment volume of up to 15 million per portfolio company.
The firm has offices in Germany, the USA and China, and a representative in Israel. It primarily invests in start-ups in highly attractive markets with above-average growth rates in the areas of Nutrition & Care, Specialty Additives and Smart Materials. A particular focus of its investment activities are the Evonik Innovation Growth Fields as well as enabling digital technologies.